MDMA 2019 Annual Meeting

MDMA’s Annual Meeting will cover key issues impacting the United States’ leadership position in med tech innovation and how we can all help shape the regulatory and legislative agendas.

Engage with industry executives, government officials and expert panelists on critical issues; Hear first hand updates on the latest news and must have information for MedTech CEOs.


 

Wednesday, May 1, 2019

3:00pm – 5:30pm

Early Registration– Algonquian Room

Attendees are encouraged to come and pick up their meeting booklet, name tag and other information prior to the opening reception.

5:30pm – 7:00pm

Opening Reception – Algonquian Room

Enjoy networking with medical technology executives and other industry leaders while hearing from leading Members of Congress who are driving health care policy.

  • Chairperson Cheri Bustos - IL* - 17th District
  • Senator Bill Cassidy - LA*
  • Senator Maggie Hassan - NH*

*pending Congressional schedule

Thursday, May 2, 2019

7:00am –  8:00am  

Networking Continental Breakfast – Waterside 3/Potomac Hall

8:00am – 8:15am

Welcome Address – Waterside 1&2

MDMA’s Chairman of the Board and MDMA’s President and CEO will provide a review of Congressional activities and work with regulatory agencies to protect America’s global leadership position in medical technology.

  • Paul LaViolette, Chairman, MDMA Board of Directors, Executive Chairman
  • Mark Leahey, President & CEO, MDMA

8:15am – 8:30am

Opening Address – Waterside 1&2

One of the top policy makers in the House of Representatives and the lead author of the "21st Century Cures Act" will share his thoughts on transforming the delivery of health care and other priorities that Congress is working on.

  • Congressman Fred Upton - MI - 6th District

8:30am – 9:00am   

Keynote Address – Waterside 1&2

Legislation and regulations with the best of intentions can never achieve their objectives without the proper implementation.  Hear from a member of FDA’s leadership team on how they are improving the agency’s efficiencies while working closely with Congress and other policy makers.

  • Amy Abernethy, MD, PhD, Principal Deputy Commissioner, FDA

9:00am – 9:45am  

CDRH Town Hall – Waterside 1&2

MDMA’s popular interactive session will host the CDRH Director to answer your questions and share his insights on the agency’s latest reform efforts and how the reorganization will impact the regulatory pathways, as well as what changes we can expect with a new FDA Commissioner and leadership.

  • Jeffery Shuren, MD, Director, CDRH, FDA

9:45am – 10:00am

NESTcc Update – Waterside 1&2

The collection of real-world evidence continues to evolve and influence regulatory and clinical decision-making. Learn from the director of the Coordinating Center on how they are working with innovators and regulators to maximize improvements.

  • Rachel Fleurence, PhD, Executive Director, National Evaluation system for health Technology (NEST)

10:00am – 10:15am

Networking Break

10:15am – 11:00am

Impact of MedTech – Waterside 1&2

Hear powerful stories about the impact of medical technology on the lives of patients, as well as how our industry is looking to solve challenges facing under-served populations and disease states, and how we can all play a role in driving down healthcare costs and improving patient outcomes.

  • Tim Ring, Co-Founder, TeamFund
  • Patient Advocates

11:00am – 11:30am

CMS Update – Waterside 1&2

From new payment models and pilot programs intended to transform patient care, CMS continues to be at the forefront of policymaking.  Hear from one of CMS’ top leaders on how they are examining value and seeking input from innovators, and how all stakeholders can work to improve the process.

11:30am – 12:15pm

Accelerating Patient Access to Technology – Waterside 1&2

As innovators, you know your technologies are only transformative when they can be accessed by patients and providers.  As CMS continues to debate new pathways for securing coverage and reimbursement, learn how the agency can work with you and your team to achieve the common goal of improved outcomes.

  • Tamara Syrek Jensen, Director, Coverage and Analysis Group, Centers for Medicare & Medicaid Services
  • Louis Jacques, Senior Vice President & Chief Clinical Officer, ADVI

12:15pm – 1:30pm

Networking Lunch – Waterside 3

1:30pm – 2:15pm

Private Payor Perspective – Waterside 1&2

Private payors have increasingly instituted new programs and processes for medical technology innovators to secure coverage, providing opportunities AND challenges.  Hear from some of the industry’s leading experts on what you and your teams need to prepare for in this changing landscape, and what they are looking for in today’s marketplace.

  • Ralph Hall, Principal, Leavitt Partners (moderator)
  • Parashar Patel, Senior Advisor, Health Policy & Payment, Market Access Strategies
  • Private Payor Representative

2:15pm – 5:30pm   

Congressional Fly-In

Congressional Fly-In Meeting participants will attend Hill meetings with their respective Senators and Representatives to discuss issues affecting the medical technology industry.

5:30pm – 7:00pm

Chairman’s Reception – Seaport

Enjoy networking with medical technology executives, government officials and other industry leaders while honoring Members of Congress who have been strong voices to restore predictability and transparency in the regulatory process, improve the reimbursement landscape and repeal the medical device tax.

Friday, May 3, 2019

 

8:00am – 8:30am 

Networking Continental Breakfast – Waterside 3


8:30am - 9:15am     

Cybersecurity – Waterside 1&2

Medical technologies increasingly incorporate digital capabilities, software and more into their products, and challenges related to cybersecurity have also grown.  Some of the nation’s leading experts who are navigating these challenges are working with medtech innovators, and they will share their “best practices” and how we can all work together to protect the safety and security of patients.

  • Greg Garcia, Executive Director for Cybersecurity, Healthcare Sector Coordinating Council (HSCC)
  • Colin Morgan, CISSP, CISM, GPEN, Managing Director, Apraciti, LLC

9:15am – 10:15am   

BREXIT: Deal or No Deal, Finding an EU Notified Body, and How Will Trade Spats with China, India, Canada, and Mexico Affect You?  Waterside 1&2

With the ongoing confusion and tension over BREXIT, there will be new trade relationships and uncertainties for you to navigate between the U.K. and the E.U.  There also remains concerns over the transition period to CE mark using the new EU Medical Device Regulation (MDR), upcoming debates in Congress over the new U.S./Mexico/Canada Trade agreement (USMCA), and shifting deadlines for a new agreement on U.S.-China trade.  Learn from top experts how you can safely navigate through these new channels of trade.

  • Richard Phillips, Director, Healthcare Policy, Association of British Healthcare Industries (ABHI)
  • Edward Rozynski, Senior International Advisor, MDMA
  • Richard Steffens, Deputy Assistant Secretary for Western Hemisphere, U.S. Department of Commerce

10:15am – 11:00am

What Would You Do? A Day in the Life of a Chief Compliance Officer – Waterside 1&2

In this interactive session, experienced compliance officers and attorneys will examine real-life scenarios and best practices for minimizing risk and improving ethics in your organization.

  • Carolyn Bruguera, Vice President & General Counsel, MDMA
  • Stuart Kurlander, Partner, Latham & Watkins LLP
  • Jill Mason, Chief Ethics and Compliance Officer, Orthofix, Inc.
  • John Richter, Partner, King & Spalding

11:00am – 1:00pm  

Networking & Boxed Lunch - Seaport/Waterside 3

Event Properties

Event Date 05-01-2019
Event End Date 05-03-2019
Individual Price $1,195.00
Location Intercontinental Hotel - The Wharf
Attachment 2019_MDMA_Annual_Meeting_Age.pdf
We are no longer accepting registration for this event

Location Map